Aspen Aerogels (NYSE:ASPN) Releases Q1 2025 Earnings Guidance

Aspen Aerogels (NYSE:ASPN) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of -0.180-0.000 for the period, compared to the consensus estimate of 0.080. The company issued revenue guidance of $75.0 million-$95.0 million, compared to the consensus revenue estimate of $104.2 million.

Aspen Aerogels Stock Performance

ASPN stock traded down $0.36 during trading on Wednesday, reaching $11.78. 3,980,989 shares of the stock were exchanged, compared to its average volume of 1,581,189. The stock has a 50 day simple moving average of $12.41 and a 200-day simple moving average of $18.68. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $966.55 million, a P/E ratio of 1,179.18 and a beta of 2.14. Aspen Aerogels has a twelve month low of $10.67 and a twelve month high of $33.15.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. As a group, sell-side analysts anticipate that Aspen Aerogels will post 0.12 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on ASPN shares. Canaccord Genuity Group cut their price target on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. HC Wainwright restated a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Piper Sandler decreased their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Roth Mkm reduced their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Finally, Barclays dropped their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and an average price target of $29.11.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.